Klotho Neurosciences, Inc. (KLTO) Dividend History

Klotho Neurosciences, Inc. is a biotechnology company focused on developing therapies targeting neurodegenerative diseases. The company aims to leverage its proprietary research in neurobiology to create innovative treatments for conditions such as Alzheimer's and other age-related cognitive disorders.

1115 Broadway, New York, NY, 10010
Phone: 646-916-5315
Website: https://www.klothoneuro.com

Dividend History

Klotho Neurosciences, Inc. currently does not pay dividends

Company News

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

Klotho Neurosciences has partnered with AAVnerGene to enhance gene therapy manufacturing processes for neurological disease treatments, focusing on more efficient and cost-effective AAV vector technologies.

Benzinga
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Klotho Neurosciences, a biotechnology company focused on developing cell and gene therapies for neurodegenerative diseases, will present at the Biotech Showcase 2025 conference during the J.P. Morgan Healthcare Week in San Francisco.

GlobeNewswire Inc.

Page data last updated 08/19/2025 17:06:23 UTC